| Primary |
| Nuclear Magnetic Resonance Imaging |
49.3% |
| Nuclear Magnetic Resonance Imaging Brain |
8.2% |
| Angiogram |
6.8% |
| Atrial Fibrillation |
4.1% |
| Scan With Contrast |
4.1% |
| Angioplasty |
2.7% |
| Diagnostic Procedure |
2.7% |
| Encephalitis |
2.7% |
| Tinnitus |
2.7% |
| Venogram |
2.7% |
| Arteriovenous Fistula Thrombosis |
1.4% |
| Biliary Tract Disorder |
1.4% |
| Blindness Unilateral |
1.4% |
| Cardiac Disorder |
1.4% |
| Cardiac Stress Test |
1.4% |
| Cerebrovascular Accident |
1.4% |
| Coma |
1.4% |
| Computerised Tomogram |
1.4% |
| Fistulogram |
1.4% |
| Hypoaesthesia |
1.4% |
|
| Nephrogenic Systemic Fibrosis |
20.9% |
| Nephrogenic Fibrosing Dermopathy |
19.4% |
| Skin Hypertrophy |
6.0% |
| Urticaria |
6.0% |
| Vomiting |
6.0% |
| Paraesthesia |
4.5% |
| Pruritus |
4.5% |
| Wheelchair User |
4.5% |
| Pharyngeal Oedema |
3.0% |
| Post Procedural Complication |
3.0% |
| Skin Discolouration |
3.0% |
| Swelling |
3.0% |
| Throat Tightness |
3.0% |
| Vision Blurred |
3.0% |
| Wheezing |
3.0% |
| Acute Generalised Exanthematous Pustulosis |
1.5% |
| Anaphylactic Reaction |
1.5% |
| Anaphylactic Shock |
1.5% |
| Blood Pressure Increased |
1.5% |
| Cardiac Arrest |
1.5% |
|
| Secondary |
| Nuclear Magnetic Resonance Imaging |
25.1% |
| Nuclear Magnetic Resonance Imaging Brain |
24.4% |
| Angiogram |
8.8% |
| Imaging Procedure |
6.2% |
| Hypertension |
5.3% |
| Prophylaxis Against Transplant Rejection |
3.0% |
| Supplementation Therapy |
3.0% |
| Chemotherapy |
2.6% |
| Pain |
2.6% |
| Mineral Supplementation |
2.5% |
| Vitamin Supplementation |
2.3% |
| Nuclear Magnetic Resonance Imaging Abdominal |
2.0% |
| Diabetes Mellitus |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Scan |
1.7% |
| Fistulogram |
1.6% |
| Venogram |
1.6% |
| Analgesia |
1.3% |
| Dialysis |
1.1% |
| Drug Use For Unknown Indication |
1.0% |
|
| Nephrogenic Systemic Fibrosis |
13.8% |
| Oedema Peripheral |
12.3% |
| Lymphadenopathy |
10.4% |
| Vision Blurred |
9.7% |
| Splenomegaly |
7.8% |
| Scar |
7.5% |
| Skin Tightness |
6.0% |
| Vomiting |
6.0% |
| Ventricular Tachycardia |
4.5% |
| Wound |
3.7% |
| Skin Ulcer |
2.2% |
| Spinal Column Stenosis |
2.2% |
| Transplant Failure |
2.2% |
| Weight Decreased |
2.2% |
| Vertigo |
1.9% |
| Off Label Use |
1.5% |
| Spinal Osteoarthritis |
1.5% |
| Upper Extremity Mass |
1.5% |
| Urticaria |
1.5% |
| Wound Infection Staphylococcal |
1.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.0% |
| Migraine |
13.6% |
| Septic Embolus |
11.9% |
| Nuclear Magnetic Resonance Imaging |
8.5% |
| Product Used For Unknown Indication |
8.5% |
| Pain |
6.8% |
| Breast Cancer |
5.1% |
| Flatulence |
5.1% |
| Diagnostic Procedure |
3.4% |
| Abdomen Scan |
1.7% |
| Abdominal X-ray |
1.7% |
| Colon Cancer Metastatic |
1.7% |
| Colonoscopy |
1.7% |
| Grand Mal Convulsion |
1.7% |
| Hypothalamo-pituitary Disorder |
1.7% |
| Investigation |
1.7% |
| Irritable Bowel Syndrome |
1.7% |
| Optic Neuritis |
1.7% |
|
| Nephrogenic Systemic Fibrosis |
50.0% |
| Asthenia |
3.8% |
| Blood Pressure Increased |
3.8% |
| Cytolytic Hepatitis |
3.8% |
| Disseminated Intravascular Coagulation |
3.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.8% |
| Nephropathy Toxic |
3.8% |
| Painful Defaecation |
3.8% |
| Pancreatitis |
3.8% |
| Pulmonary Function Test Abnormal |
3.8% |
| Sepsis |
3.8% |
| Streptococcal Infection |
3.8% |
| Throat Irritation |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
|
| Interacting |
| Depressed Mood |
25.0% |
| Metastases To Bone |
25.0% |
| Multiple Sclerosis |
25.0% |
| Nuclear Magnetic Resonance Imaging Brain |
25.0% |
|
| Renal Failure Acute |
50.0% |
| Weight Increased |
50.0% |
|
